BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26691213)

  • 1. YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.
    Di Agostino S; Sorrentino G; Ingallina E; Valenti F; Ferraiuolo M; Bicciato S; Piazza S; Strano S; Del Sal G; Blandino G
    EMBO Rep; 2016 Feb; 17(2):188-201. PubMed ID: 26691213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.
    Escoll M; Gargini R; Cuadrado A; Anton IM; Wandosell F
    Oncogene; 2017 Jun; 36(25):3515-3527. PubMed ID: 28166194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
    Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-SaccĂ  M
    J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.
    Murakami S; Nemazanyy I; White SM; Chen H; Nguyen CDK; Graham GT; Saur D; Pende M; Yi C
    Dev Cell; 2019 Oct; 51(1):113-128.e9. PubMed ID: 31447265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
    Ferraiuolo M; Verduci L; Blandino G; Strano S
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner.
    Lee Y; Kim NH; Cho ES; Yang JH; Cha YH; Kang HE; Yun JS; Cho SB; Lee SH; Paclikova P; Radaszkiewicz TW; Bryja V; Kang CG; Yuk YS; Cha SY; Kim SY; Kim HS; Yook JI
    Nat Commun; 2018 Jun; 9(1):2301. PubMed ID: 29895829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications.
    Chae SW; Sohn JH; Kim DH; Choi YJ; Park YL; Kim K; Cho YH; Pyo JS; Kim JH
    Yonsei Med J; 2011 May; 52(3):445-53. PubMed ID: 21488187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.
    Vigneron AM; Ludwig RL; Vousden KH
    Genes Dev; 2010 Nov; 24(21):2430-9. PubMed ID: 21041411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP.
    Bui DA; Lee W; White AE; Harper JW; Schackmann RC; Overholtzer M; Selfors LM; Brugge JS
    Sci Signal; 2016 Mar; 9(417):ra23. PubMed ID: 26933062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.
    Miao J; Kyoyama H; Liu L; Chan G; Wang Y; Urisman A; Yang YL; Liu S; Xu Z; Bin H; Li H; Jablons DM; You L
    J Cell Mol Med; 2020 Jan; 24(1):1087-1098. PubMed ID: 31755214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor.
    Jung MS; Yun J; Chae HD; Kim JM; Kim SC; Choi TS; Shin DY
    Oncogene; 2001 Sep; 20(41):5818-25. PubMed ID: 11593387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP enhances autophagic flux to promote breast cancer cell survival in response to nutrient deprivation.
    Song Q; Mao B; Cheng J; Gao Y; Jiang K; Chen J; Yuan Z; Meng S
    PLoS One; 2015; 10(3):e0120790. PubMed ID: 25811979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
    Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
    Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP promotes breast cancer metastasis by repressing growth differentiation factor-15.
    Wang T; Mao B; Cheng C; Zou Z; Gao J; Yang Y; Lei T; Qi X; Yuan Z; Xu W; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1744-1753. PubMed ID: 29499325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TEAD-mediated transcription controls cellular senescence.
    Xie Q; Chen J; Feng H; Peng S; Adams U; Bai Y; Huang L; Li J; Huang J; Meng S; Yuan Z
    Cancer Res; 2013 Jun; 73(12):3615-24. PubMed ID: 23576552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
    Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
    Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse.
    Corvaisier M; Bauzone M; Corfiotti F; Renaud F; El Amrani M; Monté D; Truant S; Leteurtre E; Formstecher P; Van Seuningen I; Gespach C; Huet G
    Oncotarget; 2016 Aug; 7(35):56699-56712. PubMed ID: 27527859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
    Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
    Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.